Financial Ratios

REGENCY HOSPITAL LTD.

NSE : NABSE : 526403ISIN CODE : INE581K01010Industry : Hospital & Healthcare ServicesHouse : Private
BSE52.000 (0 %)
PREV CLOSE ( ) 52.00
OPEN PRICE ( ) 48.15
BID PRICE (QTY) 52.00 (2169)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5798
TODAY'S LOW / HIGH ( )48.10 52.30
52 WK LOW / HIGH ( ) 48.152.9
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)20.9319.44-4.955.312.02
   CEPS(Rs)41.0238.0612.9414.9911.28
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)145.34124.14105.27111.40106.08
   Tax Rate(%)30.8725.3217.9046.4829.95
Margin Ratios
   Core EBITDA Margin(%)21.1321.1312.7816.5913.88
   EBIT Margin(%)15.3616.025.7112.238.39
   Pre Tax Margin(%)10.0210.06-3.215.501.79
   PAT Margin (%)6.927.51-2.642.941.26
   Cash Profit Margin (%)13.5714.706.918.307.01
Performance Ratios
   ROA(%)5.275.23-1.561.850.76
   ROE(%)15.5316.95-4.574.892.02
   ROCE(%)15.8314.944.539.946.55
   Asset Turnover(x)0.760.700.590.630.61
   Sales/Fixed Asset(x)1.050.950.750.790.74
   Working Capital/Sales(x)-44.13-12.67-5.03-13.61-17.70
Efficiency Ratios
   Fixed Capital/Sales(x)0.951.051.331.261.34
   Receivable days39.7426.2241.1053.2952.05
   Inventory Days10.3110.8114.6114.3513.61
   Payable days105.69113.87157.10182.68171.26
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)0.370.510.740.620.67
   EV/Core EBITDA(x)1.662.224.843.524.44
   EV/EBIT(x)2.383.2112.935.067.96
   EV/CE(x)0.290.320.420.370.39
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)16.7638.133.7812.2327.72
   Core EBITDA Growth(%)10.68110.25-9.9731.3537.36
   EBIT Growth(%)11.93287.76-51.5563.6328.90
   PAT Growth(%)7.65493.12-193.07162.9120.93
   EPS Growth(%)7.65493.12-193.07162.9115.81
Financial Stability Ratios
   Total Debt/Equity(x)0.891.521.311.061.03
   Current Ratio(x)0.930.850.500.810.85
   Quick Ratio(x)0.830.800.400.700.75
   Interest Cover(x)2.872.690.641.821.27
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.